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The Problem of 
Evaluating New Drugs 
*J. G. Graca, PhD. 
THE PRESENT RAPID developments 
in drug therapy pose a serious pro-
blem for the busy practitioner-young or 
old. The older veterinarian may recall 
with some nostalgia how his training in 
therapeutics involved a comparatively few 
"tried and true" drugs with which he en-
tered his practice. New drugs appearing 
at relatively infrequent intervals were 
added to his armamentarium and he had 
time to evaluate them for himself more or 
less at leisure. These were then added to 
his "Materia Medica" or discarded. Re-
cent advances in all phases of medical sci-
ences began to add many new words to 
his professional vocabulary and his inter-
pretation of new drug activities had to be 
evaluated in terms of vitamins, endoc-
rines, chemotherapy, antibiotics and a 
host of other developments based on a 
more itimate knowledge of the intricate 
nature of physiological mechanisms. In 
the light of this newer knowledge, synthe-
tic drugs are now almost tailor-made for 
specific clinical entities while some of the 
old stand-bys have undergone refinement 
with increasing potency. Newer vogues 
in medication, particularly the increased 
use of parenteral drug administration, 
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have also added to the problem. The ex-
perienced clinician can sympathize with 
the recent graduate and the student who 
must face the same problems in drug 
evaluation with very limited experience 
to draw upon. An added harassment, par-
ticulary to the already overcrowded 
student, has been the adoption of the met-
ric system in dosage computations as "of-
ficial" in the United States Pharmacopeia 
and the National Formulary. Since the 
apothecary system is still widely used, 
conversions between the metric and apo-
thecary systems must be learned. 
The establishment of ethical drug 
houses with competent research and cli-
nical facilities, producing new drugs with 
high standards of uniformity and quality 
is another facet in this changing picture. 
The decreasing use of extemporaneous 
prescriptions and the increasing use of 
compounded drug preparations is also 
evident. In using the former, the practi-
tioner must know the related activities of 
the components, while in the latter these 
factors are presumably evaluated for him. 
Many preparations are now on the market 
that differ only in minor variations of the 
formula but are sold under different trade 
name. Indeed, many drugs differ in name 
only! This is true even of some of the of-
ficial drugs, where the names seem to be 
official only from one edition to another. 
77 
For example, the proprietary "Demerol" 
was once officially listed as Isonepicaine 
and then changed to Meperidine. The 
"unit" of digitalis has undergone several 
revisions in standardization from cats to 
frogs to pigeons. To have significance, the 
digitalis unit must be qualified to the edi-
tion of the USP. 
Finally, there is an increasing interest 
and knowledge on the part of clients in 
new therapeutic advances from drug 
house advertisements and in articles in 
the popular press. Information from these 
sources may provide difficulties to the 
busy veterinarian particularly in the 
ready availability of some of these potent 
drugs to the laity, or sometimes almost 
on insistence by the client to use some of 
the new but clinically unproven drugs. 
From newspaper accounts clients are 
more aware of the publicized anticipated 
benefits than they are of the potential 
hazards which are inherent in all potent 
drugs. Experiences with the antibiotics 
may serve as a case in point without fur-
ther comment. The practitioner is anxious 
to pass on the benefits of new therapeutic 
advances to his clients, but must be as-
sured in his own mind that these new 
drugs will actually produce the benefits 
attributed to them without being to:) 
hazardous or creating new problems. It is 
obvious that the practitioner cannot place 
under clinical trials the many new drugs 
that appear almost daily so he must place 
reliance upon the reports of the work of 
others and interpret their finding in the 
light of his own experience and thera-
peutic wants. 
There are several sources of infor-
mation on new drugs. It might be pointed 
out here that really "new" drugs repre-
sent only a small fraction of the many pre-
parations put out as new drugs each year. 
Most therapeutic innovations are old 
friends easily recognized by reading the 
label beyond the properietary name. In 
the-normal course of development leading 
to the marketing of a new product, "pre-
liminary" reports and some fundamental 
studies are first reported in the journals 
of basic sciences. The exceptions to this 
are usually those drugs developed by drug 
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manufacturers in their own experimental 
laboratories. As business firms they are 
rightfully protecting their investments. 
Further, many compounds with academic 
research backgrounds have been develop-
ed into useful drugs by these firms. 
Studies are made on the mechanisms of 
action; the determination of therapeutic 
levels, toxicities and on a number of cli-
nical trials, after which the drug is evalu-
ated by the Food and Drug Administra-
tion. It may then be marketed with or 
without restriction according to the ruling 
of this federal agency. The results of the 
clinical trials and other data are then pub-
lished in a scientific journal or through 
advertisements of the manufacturer. Af-
ter the drug becomes rather widely dis-
tributed, other reports may be published 
on the therapeutic usefulness and clinical 
experiences with the drug under field 
conditions. Controlled laboratory and cli-
nical studies establish the validity of a 
new drug, and field experiences establish 
its practical usefulness. 
A comparatively recent embellishment 
of reports on new drugs, and biological 
data in general, has been the inclusion of 
a statistical analysis of the experimental 
or controlled clinical results. This sancti-
fication of results has largely replaced 
the "average" which is more a measure 
of direction than degree. Some animals 
may show no response to an "average" 
dose, while for others this dose may be 
toxic. 
The primary purpose of significance 
studies obtained through statistical analy-
sis is to point out the probabilities of 
events which can occur under a given set 
of circumstances. These methods have 
been formalized in many ways, such as 
the determination of normal probability, 
law of alternative probabilities, permuta-
tions and combinations, binomial law, the 
law of small probability (Poisson's law) 
and many others. An important point 
which is overlooked all too frequently 
is that statistical proof is offered to sup-
port conclusions obtained in experimental 
work and not necessarily to justify them. 
Much so-called scientific "proof" offered in 
a statistical form may prove to be a pitfall. 
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For example, a pollster random sampling 
in a railroad station might find that 60 
percent of the people there are going on a 
trip. By repeated observation and statis-
tical analysis he may be able to draw 
valid conclusions and predictions on 
travel habits. He would not, of course, 
be justified in concluding that 60 percent 
of the population travels. In other words, 
statistics have to be coupled with a cer-
tain amount of horse-sense in evaluating 
data. I t is not the purpose here to dis-
cuss statistical methods but it should be 
recognized that significance studies of 
data by competent analysts have contribu-
ted much in the evaluation of new drugs 
particularly in posology and toxicology. 
Although many individuals are not 
versed in the intricacies of statistical de-
velopment, they should have some guide-
posts for evaluating the various reports 
they receive. A practitioner does not 
necessarily have to be a statistician in 
order to gain knowledge from a statistical 
interpretation any more than a car driver 
has to be a mechanical engineer. As stated 
previously, most new drugs are actually 
modifications of drugs with established 
clinical usefulness altered in form, vehicle 
or combined with other drugs. Evaluation 
may be made beyond the claims for the 
drug on the basis of personal experience 
with the parent compound and what al-
terations can contribute to improving the 
product. Reports on drugs with which the 
reader has limited or no experience and 
which therefore have to be evaluated on 
the basis of the report fall into one of three 
catagories: 
First, there is the type of report con-
taining generalized unsupported claims 
for a product, liberal in terminology and 
short on facts, characteristic of too many 
types of advertising. The terms "scienti-
fically proven," "laboratory tested," "used 
by thousands" are examples of generali-
zations which are actually meaningless 
without elaboration or substantiation. It 
is possible for someone to exploit a drug 
as "laboratory tested" and actually be able 
to verify the statement. Indeed, it may 
have been laboratory tested and found 
ineffective or even toxic! In other words, 
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such statements contain important omis-
sions. If there is merit in products pro-
moted in this manner at least sources of 
evidence to support the statements should 
be mentioned so that the reader may be 
able to obtain further information if he 
so desires. Testimonials and letters of re-
commendations from consumers may also 
be included in this category. Since they 
are expressions of opinion only, they are 
not worth much, particularly since com-
plaints are so carefully excluded. 
Second, there is the type of report 
which contains the essential elements of a 
valid report but is incomplete. Every re-
searcher recognizes that two factors must 
be included in every investigation. These 
are controlled conditions for replication 
of experiments and a sufficient number of 
trials for drawing the necessary conclus-
ions. The incompleteness of reports in this 
category may result either in insufficient 
numbers of cases to draw conclusions, or 
failure to report the total number of tests. 
For example, a report on blood levels of 
a given drug has no significance if studies 
are made on only two animals, particul-
arly if they show wide variation. If at 
four hours the blood level of the drug is 
25 milligrams per 100 cubic centimeters in 
one animal, and 5 milligrams per 100 cubic 
centimeters in the other, a conclusion can-
not validly be drawn by interpolation that 
the average blood level for this drug is 
the average of the two results. One may 
presume that a third test might fall in be-
tween the two levels, but has no more as-
surance of that than the probability of 
getting a 100 milligram blood level. The 
smallest sample which may validly. be 
treated statistically is six tests under the 
same conditions. This does not mean, how-
ever, that by mathematical manipulation 
one can justify his conclusions. It means 
only that on the basis of the results obtain-
ed, one may expect that in another series 
of tests, the probabilities of obtaining the 
same results as found in the first six tests 
may be quite accurately predicted. In 
the example of the blood levels referred to 
above, the drug levels could vary between 
5 and 25 milligrams per 100 cc. or they 
could vary between 5 and 7 four out of 
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five times and have one result quite out-
side this range. Statistics will tell the in-
dividual how often in further trials he 
can expect a recurrence of these pheno-
menon. As a "rule of thumb" a variation 
of plus or minus 20 percent is considered 
as being within "normal" range. Also, it 
has been established that if a test is re-
peated 30 times (considered statistically 
as a large sample) that 90 percent of error 
due to chance is eliminated. In other 
words, that in repeating a biological test 
30 times, one can predict, within the range 
of results obtained previously, that the 
anticipated results will fall within that 
range at least 90 percent of the time. The 
other shortcoming of this category is the 
failure to report control studies, or to 
state the total number of cases on which 
the conclusions in the report are based. 
For example, a statement that "25 patients 
were successfully treated with our drug 
after other drugs had failed" even if in-
stances are cited, is significant only when 
this includes a summary of the total num-
ber treated and that the conditions were 
similiar in all situations. Successful treat-
ment of 25 out of 25 is excellent, but what 
if these successful treatments represented 
25 out of a thousand? In summary, results 
should be interpreted in the light of the 
conditions under which the tests were 
conducted, the total number of trials and 
include the failures as well as the succes-
ses in the tests. There are no perfect drugs 
as yet, and the practitioner has the right 
to know what his chances of success with a 
given product should be. 
Third, there is the type of report which 
contains all the necessary information 
from which the veterinarian may evaluate 
the drug for himself. 
He is not being "sold" anything. Com-
plete information is presented and the 
conclusions are drawn by the reader. 
These are the types of reports which ap-
pear in professional journals and in some 
of the literature supplied by reputable 
drug houses and represent a professional 
approach to an important problem. Any 
practitioner who uncritically tries a drug 
"to see if it is any good" is hardly in a 
position to criticize the layman who tries 
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a proprietary remedy on the ::;ame basis 
before calling the veterinarian. 
LINKS OF REMEMBRANCE 
A hungry dog once wandered 
Into a butcher store; 
The butcher threw some sausage 
To the dog upon the floor. 
The butcher said, "Now eat it." 
The dog said, "I decline, 
For in that link of sausage is 
That 'Ole Gal of Mine.' " 
Gestation periods vary by breeds. When 
two variant breeds are crossed, the length 
of the gestation period of the crossbred 
female is intermediate to the two parent 
breeds. 
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